Capstone Investment Advisors’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-92,372
Closed -$17.4K 2567
2024
Q1
$17.4K Hold
92,372
﹤0.01% 2275
2023
Q4
$15K Hold
92,372
﹤0.01% 2054
2023
Q3
$40.9K Hold
92,372
﹤0.01% 2031
2023
Q2
$34.1K Hold
92,372
﹤0.01% 1790
2023
Q1
$168K Hold
92,372
﹤0.01% 1302
2022
Q4
$191K Hold
92,372
﹤0.01% 1310
2022
Q3
$278K Hold
92,372
﹤0.01% 1403
2022
Q2
$296K Hold
92,372
﹤0.01% 1350
2022
Q1
$596K Buy
+92,372
New +$836K ﹤0.01% 1450
2021
Q4
Sell
-100,100
Closed -$1.18M 2120
2021
Q3
$1.18M Buy
+100,100
New +$1.58M ﹤0.01% 1353

Other funds holding HLTH

Capstone Investment Advisors's HLTH Position: Q2 2024 in Review

Capstone Investment Advisors sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 92,372 shares — an estimated $17.4K sold.

Capstone Investment Advisors first reported a position in HLTH in Q3 2021 and held it in 10 quarters. The position peaked at $1.18M in Q3 2021. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Capstone Investment Advisors reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 92,372 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $17.4K.
  • Capstone Investment Advisors first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Capstone Investment Advisors's Cue Health Inc. Common Stock position peaked at $1.18M in Q3 2021.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.